QEZ-seq® Kit & Services

About EzraBio

EzraBio is a private, early-stage biotech firm founded in 2019, developing and commercializing its QEZ-seq® technology for next-generation ribosome profiling. The company operates a hybrid business model, offering complete kits, sequencing services, and data analysis solutions to the research market. Its technology promises to accelerate and improve the accuracy of translational research by bypassing cumbersome sucrose gradient centrifugation, positioning it to capture value in the growing functional genomics and diagnostics tools sector.